 | Up a level |
Lämmle, Bernhard; Vanhoorelbeke, Karen; Kremer Hovinga, Johanna A.; Knöbl, Paul (2024). 100 Years of Thrombotic Thrombocytopenic Purpura: A Story of Death and Life. Hämostaseologie, 44(1), pp. 59-73. Thieme 10.1055/a-2223-9484
Liniger, Sophia; Dantonello, Tobias; Diepold, Miriam; Aebi, Christoph; Brodard, Justine; Kremer Hovinga, Johanna A.; Rössler, Jochen Karl; Kartal-Kaess, Mutlu (2022). Severe acquired purpura fulminans in a child. Archives of disease in childhood, 107(3), p. 300. BMJ Publishing Group 10.1136/archdischild-2021-322379
Van den Berg, Jana; Kremer Hovinga, Johanna A.; Pfleger, Claudia; Hegemann, Inga; Stehle, Gregor Thomas; Holbro, Andreas; Studt, Jan-Dirk (2022). Daratumumab for immune thrombotic thrombocytopenic purpura. Blood advances, 6(3), pp. 993-997. American Society of Hematology 10.1182/bloodadvances.2021005124
van de Munckhof, Anita; Krzywicka, Katarzyna; Aguiar de Sousa, Diana; Sánchez van Kammen, Mayte; Heldner, Mirjam R.; Jood, Katarina; Lindgren, Erik; Tatlisumak, Turgut; Putaala, Jukka; Kremer Hovinga, Johanna A.; Middeldorp, Saskia; Levi, Marcel; Arnold, Marcel; Ferro, José M; Coutinho, Jonathan M (2022). Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination. European journal of neurology, 29(1), pp. 339-344. Wiley 10.1111/ene.15113
Sánchez van Kammen, Mayte; Aguiar de Sousa, Diana; Poli, Sven; Cordonnier, Charlotte; Heldner, Mirjam R.; van de Munckhof, Anita; Krzywicka, Katarzyna; van Haaps, Thijs; Ciccone, Alfonso; Middeldorp, Saskia; Levi, Marcel M; Kremer Hovinga, Johanna A.; Silvis, Suzanne; Hiltunen, Sini; Mansour, Maryam; Arauz, Antonio; Barboza, Miguel A; Field, Thalia S; Tsivgoulis, Georgios; Nagel, Simon; ... (2021). Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. JAMA neurology, 78(11), pp. 1314-1323. American Medical Association 10.1001/jamaneurol.2021.3619
Krzywicka, Katarzyna; Heldner, Mirjam R.; Sánchez van Kammen, Mayte; van Haaps, Thijs; Hiltunen, Sini; Silvis, Suzanne M; Levi, Marcel; Kremer Hovinga, Johanna A.; Jood, Katarina; Lindgren, Erik; Tatlisumak, Turgut; Putaala, Jukka; Aguiar de Sousa, Diana; Middeldorp, Saskia; Arnold, Marcel; Coutinho, Jonathan M; Ferro, José M (2021). Post-SARS-CoV-2-vaccination Cerebral Venous Sinus Thrombosis: an analysis of cases notified to the European Medicines Agency. European journal of neurology, 28(11), pp. 3656-3662. Wiley 10.1111/ene.15029
Rössler, Jochen Karl; Baumgartner, Iris; Kremer Hovinga, Johanna A. (2021). EHA Endorsement of the Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. HemaSphere, 5(11), e647. Wolters Kluwer Health 10.1097/HS9.0000000000000647
Sánchez van Kammen, Mayte; Heldner, Mirjam R.; Brodard, Justine; Scutelnic, Adrian; Silvis, Suzanne; Schroeder, Verena; Kremer Hovinga, Johanna A.; Middeldorp, Saskia; Levi, Marcel; Hiltunen, Sini; Lindgren, Erik; Mansour, Maryam; Arauz, Antonio; Barboza, Miguel A.; Zuurbier, Susanna M.; Aguiar de Sousa, Diana; Ferro, Jose M.; Fischer, Urs; Field, Thalia S.; Jood, Katarina; ... (2021). Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic. JAMA : the journal of the American Medical Association, 326(4), pp. 332-338. American Medical Association 10.1001/jama.2021.9889
Balduini, Carlo; Freson, Kathleen; Greinacher, Andreas; Gresele, Paolo; Kühne, Thomas; Scully, Marie; Bakchoul, Tamam; Coppo, Paul; Dovc Drnovsek, Tadeja; Godeau, Bertrand; Gruel, Yves; Rao, A Koneti; Kremer Hovinga, Johanna A.; Makris, Michael; Matzdorff, Axel; Mumford, Andrew; Pecci, Alessandro; Raslova, Hana; Rivera, José; Roberts, Irene; ... (2021). The EHA Research Roadmap: Platelet Disorders. HemaSphere, 5(7), e601. Wolters Kluwer Health 10.1097/HS9.0000000000000601
Brodard, Justine; Kremer Hovinga, Johanna A.; Fontana, Pierre; Studt, Jan-Dirk; Gruel, Yves; Greinacher, Andreas (2021). COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies. Journal of thrombosis and haemostasis, 19(5), pp. 1294-1298. Wiley-Blackwell 10.1111/jth.15262
Peyvandi, Flora; Cataland, Spero; Scully, Marie; Coppo, Paul; Knoebl, Paul; Kremer Hovinga, Johanna A.; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Minkue Mi Edou, Jessica; De Winter, Hilde; Callewaert, Filip (2021). Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis. Blood advances, 5(8), pp. 2137-2141. American Society of Hematology 10.1182/bloodadvances.2020001834
Cuker, Adam; Cataland, Spero R; Coppo, Paul; de la Rubia, Javier; Friedman, Kenneth D; George, James N; Knoebl, Paul N; Kremer Hovinga, Johanna A.; Lämmle, Bernhard; Matsumoto, Masanori; Pavenski, Katerina; Peyvandi, Flora; Sakai, Kazuya; Sarode, Ravi; Thomas, Mari R; Tomiyama, Yoshiaki; Veyradier, Agnès; Westwood, John-Paul; Scully, Marie (2021). Redefining outcomes in immune TTP: an international working group consensus report. Blood, 137(14), pp. 1855-1861. American Society of Hematology 10.1182/blood.2020009150
De Gaudenzi, Martina; Kremer Hovinga, Johanna A.; Rössler, Jochen; Kaess, Michael; Kartal-Kaess, Mutlu (2021). Psychische Gesundheit bei chronischen Erkrankungen am Beispiel der Hämophilie. Paediatrica, 32(2), pp. 13-16. Schweizerische Gesellschaft für Pädiatrie SGP 10.35190/d2021.2.2
Fontana, Pierre; Alberio, Lorenzo; Albisetti, Manuela; Angelillo, Anne; Asmis, Lars M; Casini, Alessandro; Gerber, Bernhard; Graf, Lukas; Hegemann, Inga; Korte, Wolfgang; Martinez, Maria; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Wuillemin, Walter A; Kremer Hovinga, Johanna A. (2020). Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab. Swiss medical weekly, 150, w20422. EMH Schweizerischer Ärzteverlag 10.4414/smw.2020.20422
Li, Ang; Kremer Hovinga, Johanna A. (2020). Laboratory surveillance of immune-mediated thrombotic thrombocytopenic purpura. Hematology. American Society of Hematology education program, 2020(1), pp. 82-84. American Society of Hematology 10.1182/hematology.2020000164
Kremer Hovinga, Johanna A.; Braschler, Thomas R; Buchkremer, Florian; Farese, Stefan; Hengartner, Heinz; Lovey, Pierre-Yves; Largiadèr, Carlo R.; Mansouri Taleghani, Behrouz; Tarasco, Erika (2020). Insights from the Hereditary Thrombotic Thrombocytopenic Purpura Registry: Discussion of Key Findings Based on Individual Cases from Switzerland. Hämostaseologie, 40(S 01), S5-S14. Thieme 10.1055/a-1282-2264
Barco, Stefano; Sollfrank, Stefanie; Trinchero, Alice; Adenaeuer, Anke; Abolghasemi, Hassan; Conti, Laura; Häuser, Friederike; Kremer Hovinga, Johanna A.; Lackner, Karl J; Loewecke, Felicia; Miloni, Erwin; Vazifeh Shiran, Nader; Tomao, Luigi; Wuillemin, Walter A; Zieger, Barbara; Lämmle, Bernhard; Rossmann, Heidi (2020). Severe plasma prekallikrein deficiency: Clinical characteristics, novel KLKB1 mutations, and estimated prevalence. Journal of thrombosis and haemostasis, 18(7), pp. 1598-1617. Wiley-Blackwell 10.1111/jth.14805
Alberio, Lorenzo A.; Angelillo-Scherrer, Anne; Asmis, Lars M.; Casini, Alessandro; Fontana, Pierre; Graf, Lukas; Hegemann, Inga; Kremer Hovinga, Johanna A.; Korte, Wolfgang; Lecompte, Thomas; Martinez, Martina; Nagler, Michael; Studt, Jan-Dirk; Tsakiris, Dimitrios A.; Wuillemin, Walter A. (2020). Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland. Swiss medical weekly, 150(w20210), w20210. EMH Media 10.4414/smw.2020.20210
Casini, Alessandro; Alberio, Lorenzo; Angelillo-Scherrer, Anne; Fontana, Pierre; Gerber, Bernhard; Graf, Lukas; Hegemann, Inga; Korte, Wolfgang; Kremer Hovinga, Johanna A.; Lecompte, Thomas; Martinez, Maria; Nagler, Michael; Studt, Jan-Dirk; Tsakiris, Dimitrios; Wuillemin, Walter; Asmis, Lars (2020). Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis. Swiss medical weekly, 150(w20247), w20247. EMH Media 10.4414/smw.2020.20247
Tarasco, Erika; Aebi-Huber, Isabella; Kremer Hovinga, Johanna A. (2020). The Hereditary TTP Registry: who we are, what we do, why you should join us. Leading Opinions. Hämatologie & Onkologie(3), pp. 6-8. Universimed
Knoebl, Paul; Cataland, Spero; Peyvandi, Flora; Coppo, Paul; Scully, Marie; Kremer Hovinga, Johanna A.; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Minkue Mi Edou, Jessica; De Winter, Hilde; Callewaert, Filip (2020). Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study. Journal of thrombosis and haemostasis, 18(2), pp. 479-484. Wiley-Blackwell 10.1111/jth.14679
Kremer Hovinga, Johanna A.; George, James N. (2020). Hereditary Thrombotic Thrombocytopenic Purpura. Reply. The New England journal of medicine, 382(4), pp. 394-395. Massachusetts Medical Society 10.1056/NEJMc1915670
Borogovac, Azra; Tarasco, Erika; Kremer Hovinga, Johanna A.; George, James N. (2020). Hypertension in patients with hereditary thrombotic thrombocytopenic purpura. eJHaem, 1(1), pp. 342-343. Wiley 10.1002/jha2.29
Orosz, Zsuzsanna Z; Bárdos, Helga; Shemirani, Amir H; Beke Debreceni, Ildikó; Lassila, Riitta; Riikonen, Antti S; Kremer Hovinga, Johanna A.; Seiler, Theo G.; van Dorland, Hendrika A.; Schroeder, Verena; Boda, Zoltán; Nemes, László; Früh Epstein, Beatrice; Nagy, Bence; Facskó, Andrea; Kappelmayer, János; Muszbek, László (2019). Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes. International journal of molecular sciences, 20(23) Molecular Diversity Preservation International MDPI 10.3390/ijms20235963
Kremer Hovinga, Johanna A.; George, James N (2019). Hereditary Thrombotic Thrombocytopenic Purpura. The New England journal of medicine, 381(17), pp. 1653-1662. Massachusetts Medical Society 10.1056/NEJMra1813013
van Dorland, Hendrika Anette; Mansouri Taleghani, Magnus; Sakai, Kazuya; Friedman, Kenneth D; George, James N; Hrachovinova, Ingrid; Knöbl, Paul N; von Krogh, Anne Sophie; Schneppenheim, Reinhard; Aebi-Huber, Isabella; Bütikofer, Lukas; Largiadèr, Carlo R.; Cermakova, Zuzana; Kokame, Koichi; Miyata, Toshiyuki; Yagi, Hideo; Terrell, Deirdra R; Vesely, Sara K; Matsumoto, Masanori; Lämmle, Bernhard; ... (2019). The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: Key findings at enrolment until 2017. Haematologica - the hematology journal, 104(10), pp. 2107-2115. Ferrata-Storti Foundation 10.3324/haematol.2019.216796
Robertz, Judith; Andres, Martin; Mansouri Taleghani, Behrouz; Koneth, Irene; Binet, Isabelle; Kremer Hovinga, Johanna A. (2019). Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab. American journal of hematology, 94(10), E259-E261. Wiley-Liss 10.1002/ajh.25583
Angelillo-Scherrer, Anne; Mansouri Taleghani, Behrouz; Förger, Frauke; Baerlocher, Gabriela M.; Pabst, Thomas; Pöllinger, Alexander; Banz, Yara; Geiser, Thomas; Kremer Hovinga, Johanna A.; Rovó, Alicia (2019). Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndrome. Blood advances, 3(17), pp. 2664-2667. American Society of Hematology 10.1182/bloodadvances.2019000465
Tiefenbacher, Stefan; Albisetti, Manuela; Baker, Peter; Kappert, Guenther; Kitchen, Steve; Kremer Hovinga, Johanna A.; Pouplard, Claire; Scholz, Ute; Ternisien, Catherine; Borgvall, Carin; Vicente, Tiago; Belyanskaya, Larisa; Walter, Olaf; Oldenburg, Johannes (2019). Estimation of Nuwiq® (simoctocog alfa) activity using one-stage and chromogenic assays-Results from an international comparative field study. Haemophilia, 25(4), pp. 708-717. Wiley 10.1111/hae.13763
Scully, Marie; Cataland, Spero R; Peyvandi, Flora; Coppo, Paul; Knöbl, Paul; Kremer Hovinga, Johanna A.; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Callewaert, Filip; Biswas, Debjit; De Winter, Hilde; Zeldin, Robert K (2019). Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. The New England journal of medicine, 380(4), pp. 335-346. Massachusetts Medical Society 10.1056/NEJMoa1806311
Diaz, Jose Antonio; Fuchs, Tobias A.; Jackson, Tatum O.; Kremer Hovinga, Johanna A.; Lämmle, Bernhard; Henke, Peter K.; Myers, Daniel D.; Wagner, Denisa D.; Wakefield, Thomas W.; Michigan Research Venous Group, for the (2013). Plasma DNA is Elevated in Patients with Deep Vein Thrombosis. Journal of vascular surgery. Venous and lymphatic disorders, 1(4), 341-348.e1. Elsevier 10.1016/j.jvsv.2012.12.002
Reese, Jessica A.; Muthurajah, Darrshini S.; Kremer Hovinga, Johanna A.; Vesely, Sara K.; Terrell, Deirdra R.; George, James N. (2013). Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatric blood & cancer, 60(10), pp. 1676-1682. Wiley-Liss 10.1002/pbc.24612
Deal, Taylor; Kremer Hovinga, Johanna A.; Marques, Marisa B.; Adamski, Jill (2013). Novel ADAMTS13 mutations in an obstetric patient with upshaw-schulman syndrome. Journal of clinical apheresis, 28(4), pp. 311-316. New York, N.Y.: Wiley-Liss 10.1002/jca.21251
Hausammann, Stefanie; Vogel, Monique; Kremer Hovinga, Johanna A.; Lacroix-Desmazes, Sebastien; Stadler, Beda M.; Horn, Michael P. (2013). Designed ankyrin repeat proteins: a new approach to mimic complex antigens for diagnostic purposes? PLoS ONE, 8(4), e60688. Public Library of Science 10.1371/journal.pone.0060688
Schmitt, Francesca; Maier, Laura Aliena; Albisetti, Manuela; Trinchero, Alice; Graf, Lukas; Hengartner, Heinz; Fontana, Pierre; von der Weid, Nicolas; Scheinemann, Katrin; von Mackensen, Sylvia; Lerch, Stefan; Reichl, Corinna; Mürner-Lavanchy, Ines; Kremer Hovinga, Johanna A.; Kaess, Michael; Kartal-Kaess, Mutlu (2023). “Hermes” - Hemophilia Related Mental Illness: A Cross-Sectional, Multicenter Study in Switzerland. Blood, 142(Supplement 1), p. 3741. American Society of Hematology 10.1182/blood-2023-189771
